Synthesis and Antiviral Activity of a Series of Novel Quinoline Derivatives As Anti-Rsv or Anti-Iav Agents
Minghua Wang,Guoning Zhang,Jianyuan Zhao,Ningning Cheng,Yujia Wang,Yuanhui Fu,Yanpeng Zheng,Juxian Wang,Mei Zhu,Shan Cen,Jinsheng He,Yucheng Wang
DOI: https://doi.org/10.1016/j.ejmech.2021.113208
IF: 7.088
2021-01-01
European Journal of Medicinal Chemistry
Abstract:We report herein the synthesis of a series of novel quinoline derivatives, based on the lead compound 1a, identified from a rRSV-mGFP high-throughput screening assay. Our results revealed that target compounds 1b, 1g-h, 1af and 1ah (IC50 = 3.10-6.93 mu M) had good in vitro activity against RSV, which were better than 1a and ribavirin. In addition, we found that compound 1g displayed the lower cytotoxicity (CC50: 2490.33 mu M) and the highest selective index (SI = 673.06), suggesting its promising potential as a candidate for further development. On the other hand, compounds 1a, 1m, 1v, 1ad-1af and 1ah-1ai (IC(50)s: 1.87-14.28 mu M) were more active against IAV than or comparable to ribavirin (IC50: 15.36 +/- 0.93 mu M). Particularly, the most active compound 1ae (IC50: 1.87 +/- 0.58 mu M) was found to be 8.2-fold more potent than the reference drug, which could inhibit the virus transcription and replication cycle at an early stage. (C) 2021 Elsevier Masson SAS. All rights reserved.